We therefore hypothesise that epigenetic priming during CLD may have implications for HCC prognosis through two possible mechanisms: by sculpting the transcriptional landscape of the emergent HCC, and by creating a permissive environment for the acquisition of genetic alterations affecting genes such as TP53 that influences outcome [70]. The gene discussed is TP53; the disease is hepatocellular carcinoma.